• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Am Thorac Soc . Long-Term Particulate Matter Exposure and Mortality in Hospitalized Patients with COVID-19 in South Korea

tetano

Editor, Senior Moderator
Ann Am Thorac Soc


. 2024 Feb 8.
doi: 10.1513/AnnalsATS.202307-607OC. Online ahead of print. Long-Term Particulate Matter Exposure and Mortality in Hospitalized Patients with COVID-19 in South Korea

Tak Kyu Oh[SUP] 1 [/SUP], Saeyeon Kim[SUP] 1 [/SUP], Dong Hyun Kim[SUP] 2 [/SUP], In-Ae Song[SUP] 3 [/SUP]



Affiliations
Abstract

Rationale: Particulate matter (PM) exposure exacerbates health outcomes by causing lung damage.
Objective: To investigate whether prior exposure to PM10 and PM2.5 was associated with clinical outcomes among patients with coronavirus disease (COVID-19).
Methods: Data from the nationwide registration database of the National Health Insurance and Korea Disease Control and Prevention Agency in South Korea were used. The study included adult patients who were admitted to monitoring centers or hospitals between October 8, 2020, and December 31, 2021, after COVID-19 confirmation. AirKorea database, which compiles air pollutant data from 642 stations in 162 cities and counties across South Korea, was used to extract data on PM levels. Average values of monthly exposure to PM10 and PM2.5 from previous year of hospital admission due to COVID-19 to the date of confirmation of COVID-19 were calculated and used to define PM exposures of patients with COVID-19.
Results: In total, 322,289 COVID-19 patients were included, and 4,633 (1.4%) died during hospitalization. After adjusting for covariates, a 1 mcg/m3 increase in PM10 and PM2.5 exposure was associated with 4% (odds ratio [OR]: 1.04, 95% confidence interval [CI]: 1.03-1.05; P<0.001) and 6% (OR: 1.06, 95% CI: 1.04-1.07; P<0.001) increase in the risk of in-hospital mortality, respectively. Additionally, a 1 mcg/m3 increase in PM10 and PM2.5 was associated with 5% (OR: 1.05, 95% CI: 1.04-1.07; P < 0.001) and 8% (OR: 1.08, 95% CI: 1.06-1.10; P<0.001) increase in the risks of requiring intensive care unit (ICU) admission and mechanical ventilation, respectively.
Conclusions: PM10 and PM2.5 exposure was associated with increased in-hospital mortality and the need for ICU admission and mechanical ventilation among COVID-19 patients in South Korea.


 
Back
Top Bottom